TheStreet.com RealMoney.com Street Insight Subscribe Now! Premium Products Customer Service

Quotes & Search
Quotes
Search Site


Advanced Search

My StockWatch
Select your StockWatch





Streaming Quotes
Premium Products
Action Alerts PLUS
The Save Safe Plan
The Short Advisor
Turnaround Report
The Tech Edge
Telecom Connection
Chartman's Top Stocks
The Trading Reports
Daily Swing Trade
TheStreet View
Professional Products
TSC Chats
Save Money Now
RealMoney.com
Cramer Radio
Cramer's Books
Portfolio Therapy
Latest Stories
Trading Track
Columnist Conversation
Trading Diary
Corrections
Customer Service
30-Day Free Trial
Help / FAQs
Account Info
Password
Logout
Research/Tools
TheStreet Notes
Equity Research
Streaming Quotes
FREE Stock Market Outlook

FREE Financial Guide

Must-Own Bargain Stocks-FREE Trial!

Options Quiz

TheStreet.com
Home
Markets
Tech Stocks
Company News
Personal Finance
TSC Audio/Video
Conference Center
Letters

Markets : FaceOff - Glenn Curtis


Oracle's No False Prophet

By Glenn Curtis
Columnist

10/11/2001 07:37 AM EDT

Last month, Oracle's (ORCL:Nasdaq - news - commentary - research - analysis) chief executive, Larry Ellison, said that he anticipates business will get worse before it gets better. So there shouldn't be any question that the company is experiencing a marked slowdown in software sales. But does this mean that investors should write off Oracle altogether? Not at all.

To be clear, in the near term, the stock could have some more downside. A drop in customer spending, particularly after last month's terrorist attacks, has made its near-term earnings outlook questionable at best. Still, I can't help but think that investors who buy the dips will fare quite well over time.

What makes me so confident?

First, let's face it -- Oracle is a survivor. Just a couple of years back, nobody could have predicted that the company would have any real success competing against the likes of Microsoft (MSFT:Nasdaq - news - commentary - research - analysis). Yet despite all odds, the company prevailed, turning in an amazing 15 consecutive years of revenue growth. These guys have evolved into a major player in both systems and Internet software. And they aren't going anywhere.

Its market position aside, investors may find some solace in Oracle's balance sheet. With more than $6 billion in cash and ample access to capital above and beyond that, the company is in an enviable position. What's the difference if the company has a lot of cash if its bread-and-butter licensing business is in the tank, you ask?

The answer's flexibility. With its deep pockets, Oracle can afford to reduce prices and make deals in order to move inventory and maintain its market position. It can also afford to plunk down a quarter-billion dollars every three months for R&D. Few other players in this space can make that same claim.

The bottom line is that Oracle's management team, technology and business plan are sound. Over the long haul I have little doubt that when this cloud of uncertainty lifts, the Oracle shareholder will be richly rewarded for his patience.


May is Long-Term Investing Month.
Please click here to see TheStreet.com's coverage of getting your portfolio in shape!



In keeping with TSC's editorial policy, Glenn Curtis doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. Curtis welcomes your feedback and invites you to send it to Glenn Curtis
Read our conflicts and disclosure policy.
Order reprints of RealMoney.com articles. Top



Click to change or update chart Click to change or update chart Click to change or update chart

WorldInvestorTile



Partner Center




© 1996-2003 TheStreet.com, Inc. All rights reserved.